STEM News Today
SEE OTHER BRANDS

Global take on science and technology news

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on August 29, 2025

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025

PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in September. Cantor Global Healthcare Conference 2025 in …

Arvinas to Participate in Upcoming Investor Conferences

Arvinas to Participate in Upcoming Investor Conferences

NEW HAVEN, Conn., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in fireside chats …

Alumis to Participate in Upcoming September Investor Conferences

Alumis to Participate in Upcoming September Investor Conferences

SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that the Company will …

Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025

Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025

IRVINE, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Cantor Global …

Aduro Clean Technologies Initiates Marketing Campaign

Aduro Clean Technologies Initiates Marketing Campaign

LONDON, Ontario, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste …

BullZilla Presale Launches on Aug 29 with Mutation Mechanism and Staking Rewards

BullZilla Presale Launches on Aug 29 with Mutation Mechanism and Staking Rewards

LONDON, Aug. 29, 2025 (GLOBE NEWSWIRE) -- The meme coin battlefield is about to awaken as BullZilla ($BZIL), an Ethereum-powered ERC-20 token, announces the launch of its highly anticipated presale. The event starts on August 29, 2025, at 6:00 p.m. GMT, …

UTStarcom Reports Unaudited Financial Results for First Half of 2025

UTStarcom Reports Unaudited Financial Results for First Half of 2025

HANGZHOU, China, Aug. 29, 2025 (GLOBE NEWSWIRE) -- UTStarcom (“UT,” “UTStarcom” or the “Company”) (NASDAQ: UTSI), a global telecommunications infrastructure provider, today reported its unaudited financial results and a business update for the six months …

Range Declares Quarterly Dividend

Range Declares Quarterly Dividend

FORT WORTH, Texas, Aug. 29, 2025 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE: RRC) today announced that its Board of Directors declared a quarterly cash dividend on its common stock for the third quarter. A dividend of $0.09 per common share is …

15 Goranson Bain Ausley Attorneys Named Best Lawyers in America® 2026 for Family Law Mediation — The Most in Texas and the United States

15 Goranson Bain Ausley Attorneys Named Best Lawyers in America® 2026 for Family Law Mediation — The Most in Texas and the United States

AUSTIN, TX, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Goranson Bain Ausley, the largest law firm in Texas exclusively dedicated to family law, is proud to announce that 15 of its attorneys have been recognized in the 2026 edition of The Best Lawyers in America® …

Prospera Energy Announces Operations Update, Closing of White Tundra Petroleum Acquisition, and Signing of Joint Venture Partnership

Prospera Energy Announces Operations Update, Closing of White Tundra Petroleum Acquisition, and Signing of Joint Venture Partnership

CALGARY, Alberta, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) (“Prospera”, “PEI” or the “Corporation”) Operations Update Prospera has maintained strong operational momentum, averaging gross production of 775 boe/d (97% …

Pandag Tech's G1 Robotic Mower Draws Strong Interest at Major Australian Agricultural Events

Pandag Tech's G1 Robotic Mower Draws Strong Interest at Major Australian Agricultural Events

GUNNEDAH, Australia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pandag Tech marked a successful Australian market debut at AgQuip and Dowerin Field Day this month, with its flagship Pandag G1 robotic mower drawing lots of professional visitors and generating …

Panasonic TOUGBOOK Showcases Mission-Ready Defence Solutions at DSEI 2025

Panasonic TOUGBOOK Showcases Mission-Ready Defence Solutions at DSEI 2025

Panasonic TOUGHBOOK to deliver immersive demonstrations of rugged, mission-ready technology aligned with the UK’s Strategic Defence Review (SDR) 2025, supporting national security and NATO interoperability at DSEI London. Bracknell, UK. 29th August 2025 – …

Bicycle Toxin Conjugates Clinical Trials FDA Approval Proprietary Technology Cancer Drugs Report 2025

Bicycle Toxin Conjugates Clinical Trials FDA Approval Proprietary Technology Cancer Drugs Report 2025

Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Bicycle Toxin Conjugates Clinical Trials, Proprietary Platforms …

RNA Polymerase I POL 1 Clinical Trials Companies FDA Approval Development Trends Report 2025

RNA Polymerase I POL 1 Clinical Trials Companies FDA Approval Development Trends Report 2025

Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global RNA Polymerase I Clinical Trials, Development Trends By Indications, Target Approaches …

Tetraspecific Antibodies Clinical Trials FDA Approval Development Technologies Platforms Market Opportunity Companies Report 2025

Tetraspecific Antibodies Clinical Trials FDA Approval Development Technologies Platforms Market Opportunity Companies Report 2025

Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Tetraspecific Antibodies Clinical Trials, Proprietary Technologies, Therapeutic Approaches …

Bispecific Antibody Drug Conjugates ADC Clinical Trials FDA Approval Companies Commercial Launch Report 2025

Bispecific Antibody Drug Conjugates ADC Clinical Trials FDA Approval Companies Commercial Launch Report 2025

Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials, Development Platforms, Competitive Landscape and Market Opportunity Insight 2025 Report Findings and Highlights: First Bispecific Antibody Drug Conjugate …

Controlled Release Drug Delivery Market Size FDA Approved Drugs Clinical Trials Companies Report 2030

Controlled Release Drug Delivery Market Size FDA Approved Drugs Clinical Trials Companies Report 2030

Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Controlled Release Drug Delivery Market, Drug Dosage, Price, Sales and Clinical Trials Insight 2030 Report Finding and Highlights: Research Methodology Followed Global and Regional Market Overview Global …

OSE Immunotherapeutics Réaffirme ses Priorités Stratégiques et Publie un Document Questions-Réponses Destiné aux Actionnaires pour Rétablir l’Information Avant l’Assemblée Générale

OSE Immunotherapeutics Réaffirme ses Priorités Stratégiques et Publie un Document Questions-Réponses Destiné aux Actionnaires pour Rétablir l’Information Avant l’Assemblée Générale

OSE Immunotherapeutics Réaffirme ses Priorités Stratégiques et Publie un Document Questions-Réponses Destiné aux Actionnaires pour Rétablir l’Information Avant l’Assemblée Générale NANTES, France - 29 août 2025, 8h00 CET – OSE Immunotherapeutics SA (ISIN: …

Falcon Oil & Gas Ltd - Filing of Interim Financial Statements

Falcon Oil & Gas Ltd - Filing of Interim Financial Statements

FALCON OIL …

OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM

OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM

OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM Nantes, August 29, 2025, 8:00 a.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today published a comprehensive …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions